Greenwich LifeSciences Inc (GLSI)
NASDAQ
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current GLSI market cap is 192.04M. The company's latest EPS is USD -0.6765 and P/E is -21.46.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.24M | -1.75M | -2.5M | -2.84M | -2.54M |
| Net Income | -2.13M | -1.63M | -2.39M | -2.75M | -2.47M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -1.86M | -4.6M | -8.04M | -9.33M |
| Net Income | -1.86M | -4.57M | -7.83M | -8.89M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 11.92M | 10.95M | 9.15M | 7M | 5.51M |
| Total Liabilities | 235k | 301k | 297k | 295k | 389k |
| Total Equity | 11.68M | 10.65M | 8.85M | 6.7M | 5.12M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 28.68M | 27.22M | 13.48M | 7M |
| Total Liabilities | 1.05M | 385k | 263k | 295k |
| Total Equity | 27.63M | 26.83M | 13.21M | 6.7M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -1.56M | -2.52M | -4.32M | -6.48M | -1.78M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | 299k |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.15M | -4.29M | -6.2M | -6.48M |
| Investing | N/A | N/A | N/A | N/A |
| Financing | 29.81M | 2.84M | -7.54M | N/A |
| Market Cap | 192.04M |
| Price to Earnings Ratio | -21.46 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 27.31 |
| Price to Book Ratio | 28.49 |
| Dividend Yield | - |
| Shares Outstanding | 13.14M |
| Average Volume (1 week) | 35.04k |
| Average Volume (1 Month) | 38.26k |
| 52 Week Change | 64.34% |
| 52 Week High | 21.44 |
| 52 Week Low | 7.58 |
| Spread (Intraday) | 0.35 (2.36%) |
| Company Name | Greenwich LifeSciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.greenwichlifesciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
